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Abstract 
Military aircraft routinely operate in harsh, corrosive environments that necessitate 
aggressive maintenance methods and products to prevent deterioration.  Three primary tasks 
associated with corrosion control of these aircraft are abrasive blasting, sanding, and primer paint 
application.  The most frequently used primer paints for these applications contain chromium VI 
(Cr VI) in the form of barium chromate and strontium chromate.  Due to aircraft size and the 
nature of these tasks, control of Cr VI exposures is often difficult.   
Numerous studies of chromate related industries have identified worker exposures in 
excess of the OSHA PEL of 5 µg/m3.  Long-term analysis of chromate workers with known Cr 
VI exposures levels have shown elevated risk of mortality due to lung cancer. These evaluations 
highlight the importance of multi-layered control systems to reduce Cr VI exposure levels. 
This goal of this study was to investigate occupational inhalation exposures to Cr VI 
during worker performed tasks for corrosion control for military aircraft.  Sample results for 
three primary tasks, abrasive blasting, sanding, and primer (paint) application, were obtained at a 
major military aircraft maintnance facility.  These results were evaluated to determine if the 
exposure distribution allowed for establishment of Similar Exposure Groups (SEGs) within the 
department.   
The results of this study found Cr VI exposures above the OSHA PEL occurred in each 
task, but that the mean exposures of each task were not significantly different.  A high degree of 
variability was observed in the overall sample set and the individual tasks.  Statistical analysis of 
the obtained data failed to justify separating the sampled tasks into separate SEGs.  Despite these 
findings, a high probability of overexposure exists to workers at this facility regardless of the 
task conducted. 
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1. Introduction 
Chromium is a metallic element that exists in the natural environment and is 
predominantly found in ores.  Occupational exposures to chromium (VI) occur in numerous 
industries and various types of processes.  These include electroplating, welding, painting, 
production of pigments, catalysts, inks, refractory bricks, Portland cement, iron and steel 
production, wood working and preserving, printing, leather tanning, solid waste incineration, and 
oil/gas drilling (L.M. Blade, 2007). Though chromium is naturally occurring in the earth’s crust, 
it is estimated that 60-70% of total atmospheric chromium stems from human industrial 
activities.  Atmospheric chromium is removed from the air through natural fallout and 
precipitation (Public Health Service, 2012).  In the natural environment, many ecosystems near 
chromium producing facilities retain and adapt to the toxic levels of chromium (VI) that have 
been introduced.  It has been estimated that nearly 38% of the drinking water supply in the state 
of California contains detectable levels of chromium (VI) (Klassen, 2013).  For humans, food is 
a predominant non-occupational source of chromium (VI), with the highest levels often found in 
meat, fish, fruits, and vegetables (Public Health Service, 2012). 
Chromium exists in several valence states; however, the trivalent (Cr III) and hexavalent 
(Cr VI) states are of primary interest from a toxicological perspective.  Cr III (an essential 
nutrient) makes up most naturally occurring chromium while Cr VI is created through many 
industrial processes.  Through reduction reactions in humans, animals, and other environmental 
material, the relatively unstable Cr VI reduces to the more stable Cr III.  When occurring in 
human tissue, this reaction releases numerous deleterious byproducts that are the causal factor 
for many acute, chronic, and carcinogenic conditions.   
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This paper will outline and discuss the toxicological effects of Cr VI in greater detail.  
The similar physical and chemical properties of Cr VI and Cr III, as well as the reduction 
reaction of Cr VI to Cr III, greatly complicate our ability to measure exposure, assess effects, and 
attribute identifiable health problems between the two valence states.  Although absorbed 
chromium is widely distributed throughout human tissues, the effects of Cr VI (and Cr III) are 
highly dependent on the route of exposure (Public Health Service, 2012).  The three primary 
routes of exposure for Cr VI are inhalation, dermal absorption, and oral ingestion.  Occupational 
exposure to Cr VI typically occurs via inhalation or dermal contact while the public is 
predominantly exposed to Cr III via ingestion (Public Health Service, 2012). 
Due to negative effects on individuals subjected to both acute and chronic exposures to 
Cr VI, it is imperative that Industrial Hygiene professionals ensure that personnel involved in 
corrosion control tasks for military aircraft are protected.  This study evaluated personnel 
assigned at a major military aircraft maintnance facility.  These personnel conducted three 
primary tasks: abrasive blasting, sanding, and primer (paint) application.  These tasks are 
performed on numerous aircraft types and included work on both full airframes as well as 
individual components.  The goal of this study was to investigate occupational exposures to Cr 
VI via inhalation during these tasks. 
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2. Background and Literature Review 
2.1. Acute and Chronic Toxicity 
Common respiratory effects observed following Cr VI inhalation exposure include acute 
symptoms of dyspnea, cough, wheezing, excessive sneezing, rhinorrhea, nasal itching, nasal 
soreness, expectoration, and nose-bleeds.  Other noted acute effects of Cr VI inhalation include 
dizziness, headache, and generalized weakness (Public Health Service, 2012).  Chronic 
respiratory effects observed from Cr VI inhalation exposure are nasal septum ulceration with or 
without perforation (Klassen, 2013).  In sensitized individuals, acute dermal reactions in the form 
of allergic dermatitis have been observed following inhalation exposures.  Chromate sensitive 
workers have also been shown to develop asthma (Public Health Service, 2012).  Cr VI is 
classified as a human carcinogen and has been shown to increase the risk of lung cancers.  There 
also exists the possibility for increased risk of cancers developing in other regions and systems of 
the body due to the wide distribution potential for inhaled Cr VI throughout the body (Klassen, 
2013).  A 15-year follow-up cohort study of over 42,000 painters identified significantly 
increased lung cancer rates over the population in direct comparison to non-painters (Steenland 
& Palu, 1999). 
2.2. Factors Influencing Toxicity 
The toxic effects of Cr VI via inhalation in industrial settings have been well studied. 
Inhalation of Cr VI primarily occurs in the form of particulates or dissolved in mists/aerosols 
(Klassen, 2013).  Particulate Cr VI deposition in the respiratory tract is dependent upon particle 
size, airway geometry, and the regional deposition mechanism.  The solubility of the inhaled Cr 
VI compound affects both the severity and location of biological damage with insoluble forms 
causing more damage in the lower respiratory tract and soluble forms damaging the nasal 
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passages (U.S. Environmental Protection Agency, 1998).  Other factors that contribute to the 
deposition mechanisms of inhaled particles are respiratory tract airflow velocities (as a function 
of ventilation via an individual’s tidal volume) as well as the activity levels of alveolar 
macrophages (U.S. Environmental Protection Agency, 1998).  In general, larger particles are 
deposited in the extrathoracic region (Public Health Service, 2012) and lower solubility 
chromium compounds reaching the pulmonary region tend to remain there longer where they are 
absorbed via the alveolar membranes (Klassen, 2013).  Inhaled Cr VI is absorbed at levels of 4-5 
times greater than that of Cr III (Klassen, 2013). 
Chromium VI absorbed into the erythrocyte is widely distributed via the bloodstream 
(Klassen, 2013).  While the highest concentrations of Cr VI are often found in the kidneys, liver, 
and spleen, significant concentrations are found in all organs including bone.  Studies supporting 
the wide distribution of chromium have shown increased chromium levels in the heart, pancreas, 
lung, and muscles.  There is also evidence to suggest that occupational exposure to chromium 
can result in transfer to fetuses via the placenta as well as infants through breast milk (Public 
Health Service, 2012). 
2.3. Biotransformation 
The principle biotransformation of Cr VI within the cells occurs via reduction 
mechanisms which ultimately result in Cr III.  The intermediate molecules and their subsequent 
oxidative reactions lead to deleterious effects and overall oxidative stress.  Upon reaching and 
entering the cells, Cr VI interacts with several intracellular compounds including ascorbic acid, 
glutathione, cysteine, hydrogen peroxide, and amino acids (Public Health Service, 2012).  These 
interactions are complex and not fully understood; however, the formation of the intermediates 
chromium V and chromium VI have been shown to produce harmful reactive oxygen species 
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through Fenton-like oxidative cycling as well as thiyl and carbon-based radicals (Giancarlo De 
Mattia, 2004). 
The stable Cr VI reduction product, Cr III, is also more capable of binding DNA.  Cells 
that are exposed to Cr VI are therefore susceptible to DNA damage through single-strand breaks, 
interstrand crosslinks, DNA-protein crosslinks, chromium-DNA adducts, oxidative nucleotide 
changes, and chromosomal aberrations (Flora, 2000).  The other reduction products 
(intermediates, radical and reactive oxygen species) are also able to attack DNA, proteins, 
(Giancarlo De Mattia, 2004) and membrane lipids through peroxidation (Public Health Service, 
2012).  The breakdown of the cellular membranes leads to disruption of cellular integrity and 
interruption of cellular communications and signaling (Public Health Service, 2012).  Due to the 
complex nature of the reduction reactions and the wide variety of intermediates formed, there is a 
lack of clear knowledge and understanding of the relative quantitative importance amongst the 
various reaction products (U.S. Environmental Protection Agency, 1998). 
2.4. Affected Organs 
Reduction of Cr VI to Cr III can occur in the lungs, the gastrointestinal tract, and the 
erythrocytes.  Following inhalation exposure, the reduction of Cr VI to Cr III occurs in the 
epithelial lining of the lungs.  This reduction occurs primarily through interaction with ascorbic 
acid, but is also affected by glutathione when ascorbic acid levels are depleted or exhausted.  Cr 
VI reduction by ascorbic acid occurs more rapidly than reduction by glutathione.  The rates of 
these reduction mechanisms are proportional to the overall residence time of Cr VI in the lungs 
(U.S. Environmental Protection Agency, 1998).  Additionally, reduction of Cr VI is 
accomplished via alveolar macrophages (Public Health Service, 2012). 
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If oral ingestion of Cr VI compounds occurs, interactions with gastric juices and ascorbic 
acid provide a primary defense against overall Cr VI absorption.  Higher concentrations of 
ascorbic acid favor reduction of Cr VI to the more stable Cr III while lower levels result in the 
more reactive Cr V molecular state (Public Health Service, 2012). 
Following absorption into the bloodstream, Cr VI uptake into erythrocytes readily occurs 
via the phosphate and sulfate anion exchange pathways.  The erythrocyte cellular membrane is 
permeable to Cr VI, but not Cr III.  As such, any chromium reduced in the red blood cells 
remains there until that cell dies (Public Health Service, 2012). 
Reduction of Cr VI to Cr III has also been shown to occur by way of microsomal 
enzymes in the liver.  Studies in rats have shown that Cr VI reduction rates are proportional to 
both the concentration of microsomal protein as well as the concentration of nicotinamide 
adenine dinucleotide phosphate (NADPH).  In these studies, it was also shown that induction of 
cytochrome P450 and NADPH-cytochrome P450 affect the rate of reduction of Cr VI to Cr III.  
Further studies have considered species differences for humans for microsomal reduction of 
chromium.  These also showed proportional changes correlating reduction rates to the levels of 
microsome.  Differences were discovered and indicated that P450 does not play a predominant 
reduction role in humans as it does in rats; however, the human liver has a greater overall 
capacity for chromium reduction (Public Health Service, 2012). 
Overall, the blood system, lungs, and gastrointestinal tract are capable of substantial Cr 
VI reduction.  Measured Cr VI reduction capacities in humans have been estimated at 0.7-2.1 
mg/day for saliva, 8.3-12.5 mg/day for gastric juices, 136 mg/hour for alveolar macrophages, 
260 mg/hour for lung epithelial lining, 93 mg/hour - 128 mg/hour for female/male red blood 
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cells, 187 mg/hour - 234 mg/hour for female/male whole blood, and 3,300 mg/hour for the liver 
(Public Health Service, 2012). 
The biotransformation of Cr VI to Cr III within the cells can be considered to have both 
toxification and detoxification effects from a carcinogenesis perspective.  When the reduction 
reactions occur within the cells, a toxification effect occurs as the production of intermediates 
and reactive oxygen species in close proximity to DNA.  However, the reduction reactions 
occurring in the gastric juices, bloodstream, and other bodily fluids yield a detoxification effect 
because Cr III is less capable of diffusing across the cellular membrane.  This distance allows the 
damaging intermediates and reactive oxygen species to remain farther from the DNA and thus 
protect the gastrointestinal tract and liver (Flora, 2000).  The location of particle deposition and 
therefore route of exposure is a key factor in overall Cr VI induced carcinogenicity (Public 
Health Service, 2012).  Thus, the respiratory tract is the primary affected target organ as the 
detoxifying reduction reactions discussed above either do not occur or may become 
saturated/overwhelmed while the compounds are resident within the tissue (Flora, 2000). 
Cr VI compounds have been classified by the NTP as “known to be human carcinogens” 
and by the IARC as “known human carcinogens” (Group 1) (Klassen, 2013). 
2.5. Dose Response Relationships 
A cohort study of over 2,000 workers employed at a chromate production facility showed 
a strong dose response relationship between cumulative exposure to Cr VI and cases of lung 
cancer (Gibbs, Lee, Pinsky, & Rooney, 2000).  Both the Agency for Toxic Substances and 
Disease Registry (ATSDR) and the Environmental Protective Agency (EPA) have evaluated 
research and studies conducted to evaluate dose-response relationships for chromium.  The 
ATSDR provides estimates of exposure levels that present Minimal Risk Levels (MRLs) to 
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humans for Cr VI.  An MRL is defined as “an estimate of daily human exposure to a substance 
that is likely to be without an appreciable risk of adverse health effects (non-carcinogenic) over a 
specified duration of exposure.”  These values are predisposed to have some level of ambiguity 
due to the techniques used and uncertainties involved in derivation and development of acute (1-
14 days), intermediate (15-364 days), and chronic (>365 days’) timeframes as well as a lack of 
data on potentially sensitive populations (Public Health Service, 2012). 
ATSDR MRLs for inhalation of Cr VI-containing compounds are available for both 
intermediate and chronic exposures.  There is limited data evaluating acute Cr VI inhalation 
exposures and many of these studies evaluated small population groups.  Also, there exists the 
possibility that some chromium sensitized individuals produce respiratory symptoms that are 
similar to non-sensitized individuals.  A lack of data providing suitable no observed adverse 
effect level (NOAEL) and lowest observed adverse effect level (LOAEL) values in animals has 
led the ATSDR to not derive acute inhalation or acute oral MRLs for Cr VI exposures (Public 
Health Service, 2012). 
A MRL for intermediate inhalation exposure of 5x10-6 mg Cr VI/m3 was derived for 
exposure to Cr VI in the form of aerosols or mists.  This MRL was based on a LOAEL value of 
0.002 mg Cr VI/m3 observed from workers exposed to chromic acid mist who reported 
symptoms of nasal irritation, mucosal atrophy, ulcerations, and decreased lung capacities.  The 
LOAEL was adjusted for a traditional work week and an uncertainty factor of 100 was applied.  
Using the same data set as a basis, a MRL for chronic inhalation exposure of 5x10-6 mg Cr VI/m3 
was derived for exposure to Cr VI in the form of aerosols or mists (Public Health Service, 2012). 
A MRL for intermediate inhalation exposure of 0.0003 mg Cr VI/m3 was derived for 
exposure to Cr VI in the form of particulates.  This MRL was determined using a benchmark 
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concentration (BMC) value of 0.016 mg Cr VI/m3 observed by bronchoalveolar lavage fluid in 
rats exposed to sodium dichromate aerosol particulates and adjusted to 0.010 mg Cr VI/m3 for 
humans.  An uncertainty factor of 30 was applied to account for species differences and 
variability.  Limited data exists that has evaluated the effects of chronic inhalation exposure for 
Cr VI particulate containing compounds; therefore, no MRL for chronic Cr VI particulate 
exposure has been derived (Public Health Service, 2012). 
In addition to exposure assessments considered by the ATSDR, the EPA has evaluated 
reference concentrations (RfCs) for non-carcinogenic dose-response for inhalation.  Two 
separate RfCs account for Cr VI inhalation exposure from both aerosols/mists and particulates.  
For each of these derivations, the EPA utilized the same data sets the ATSDR evaluated for 
inhalation MRLs discussed above.  For aerosols/mists, the LOAEL for nasal septum atrophy was 
2 µg/m3 based on an 8-hour time weighted average (TWA).  After conversion to continuous 
exposure (to 0.714 µg/m3), an uncertainty factor of 90 (3 to account for subchronic to chronic 
exposure, 3 to extrapolate from the LOAEL value to a NOAEL value, and 10 to account for 
variability in humans) was applied to generate of RfC for upper respiratory effects from Cr VI 
exposure the aerosols/mists of 0.008 µg/m3 (U.S. Environmental Protection Agency, 1998). 
For Cr VI particulates, the RfC was based on a lowest benchmark concentration (BMC) 
value of 16 µg/m3 as evidenced from bronchoalveolar lavage fluid in rats exposed to sodium 
dichromate.  Application of a regional deposited dose ratio accounting for species differences 
and the previously used uncertainty factor of 90, the RfC for Cr VI particulates is 0.1 µg/m3. 
2.6. Storage and Excretion 
Chromium that enters systemic distribution is not readily stored; however, studies have 
shown that some levels of Cr VI are retained in bone.  Elevated levels of chromium have also 
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been observed in breast milk where it could be transferred to infants.  The primary mechanism 
for removal of absorbed Cr VI is through excretion in urine.  Because Cr III is an essential 
nutrient, some levels of chromium are routinely found in urine, but these values have a high level 
of variability with or without occupational exposure.  Higher levels of occupational exposure to 
Cr VI have shown, however, correlation with urine chromium levels.  Elimination half-times of 
10-40 hours have been seen for absorbed Cr III.  Due to the absorption, an uptake of Cr VI into 
the red blood cells, the elimination half-times for Cr VI in urine may vary and should be 
evaluated in conjunction with chromium levels in the blood to determine exposure.  Chromium 
may also be excreted from the body via hair and nails (Public Health Service, 2012). 
2.7. Treatment and Therapy 
There are no existing, approved treatment procedures for Cr VI exposure.  Guidance and 
numerous recommendations exist to aid in reducing chromium absorption based on our 
knowledge of the toxicokinetics of Cr VI reduction mechanisms.  These recommendations are 
based on interfering with or modulating the biotransformation processes.  In the event of acute 
inhalation exposure to Cr VI, immediate actions include shifting the individual away from the 
exposure site and observing the individual for any symptoms of respiratory discomfort or 
distress.  If necessary, medical professionals can consider giving them supplemental oxygen or 
bronchodilator medication (Public Health Service, 2012). 
Inhaled chromium may be naturally removed from the respiratory tract by mucociliary 
action and transferred to the gastrointestinal tract.   Due to the reduction of Cr VI to Cr III by the 
gastric juices and the lower absorption rate of Cr III in the gastrointestinal system, toxicity of 
inhaled Cr VI may be reduced by giving the exposed individual expectorants to aid in this 
process (Public Health Service, 2012). 
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If efforts to limit absorption have been exhausted, any absorbed Cr VI will quickly be 
distributed throughout the body by systemic circulation via the bloodstream.  Traditional blood 
transfusions will reduce the levels of Cr VI in erythrocytes. Ascorbic acid may be administered 
intravenously to patients in order to aid in quickly reducing Cr VI to the more stable, less 
harmful Cr III.  Though not yet evaluated in or on humans, studies have shown some evidence 
that vitamins (e.g. E and B2) and essential elements (e.g. selenium) may reduce Cr VI toxicity via 
their anti-oxidant potential (Public Health Service, 2012). 
2.8. Regulatory Efforts 
The most recent, major regulatory changes for monitoring and controlling Cr VI exposure 
were passed in February 2006.  Following a lengthy period of evaluation and study (as well as 
litigation), the Occupational Health and Safety Administration (OSHA) updated, approved, and 
published the current general industry Permissible Exposure Limit (PEL) standard to 5 µg/m3 
(Anna, 2011).  The employer shall use engineering and work practice controls to reduce and 
maintain employee exposure to Cr VI to or below the PEL unless the employer can demonstrate 
that such controls are not feasible. Wherever feasible engineering and work practice controls are 
not sufficient to reduce employee exposure to or below the PEL, the employer shall use them to 
reduce employee exposure to the lowest levels achievable, and shall supplement them using 
respiratory protection that complies with the applicable requirements.  The approved PEL does 
include a provision for aerospace paint applications that consider containment issues with 
sprayed paint applications on large aircraft and assemblies (L.M. Blade, 2007).  The exception in 
the OSHA standard for the aerospace industry requires, in the cases of painting aircraft or large 
aircraft parts, that the employer must use all feasible engineering or workplace controls to reduce 
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Cr VI exposure to at or below 25 µg/m3.  Respiratory protection may be used to supplement 
other existing controls to attain the PEL of 5 µg/m3 (OSHA, 2012). 
Cr VI exposure is also regulated by the EPA.  Additionally, Cr VI guidelines and 
recommendations for exposure are provided by the ATSDR (Minimal Risk Level – MRL), the 
National Institute for Occupational Safety and Health (NIOSH) (Recommended Exposure Limit 
– REL), and the American Conference of Governmental Industrial Hygienists (ACGIH) 
(Threshold Limit Value – TLV).  Current regulated and recommended levels are shown in Table 
I.  Cr VI is classified as a carcinogen by the IARC, the NTP, the ACGIH, and the EPA.  Current 
carcinogenicity classifications are provided in Table II. 
Table I: Regulatory Standards, Recommendation, and Guidelines for Cr VI Exposure 
Agency Description Level 
OSHA 
PEL 8 hour TWA for general industry 
Aerospace industry exception with supplemental controls 
5 µg/m3 
25 µg/m3 
NIOSH REL - 8 hour TWA (all Cr VI compounds) 0.2 µg/m3 
ACGIH 
TLV - 8 hour TWA - Water-soluble Cr VI compounds 
TLV - 8 hour TWA - insoluble Cr VI compounds 
0.05 mg/m3 
0.01 mg/m3 
(OSHA, 2012) (U.S. Environmental Protection Agency, 1998) (Public Health Service, 2012)  
(NIOSH, 2017) 
Table II: Carcinogenicity Classifications for Cr VI Exposure 
Agency Description Level 
IARC Cr VI Group 1 – carcinogenic to humans 
ACGIH 
Water soluble Cr VI compounds 
Insoluble Cr VI compounds 
A1 – confirmed human carcinogen  
A1 – confirmed human carcinogen 
NTP Cr VI compounds Known to be human carcinogens 
EPA 
Cr VI – inhalation route of exposure 
 
Cr VI – oral route of exposure 
 
Group A – known human carcinogen  
 
Group D – not classified as to the 
substance human carcinogenicity 
(Klassen, 2013); (Public Health Service, 2012); (U.S. Environmental Protection Agency, 1998) 
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2.9. High Risk Groups 
There are no studies that are known to have investigated developmental effects of Cr VI 
exposure on human fetuses. In animals, some evidence has been shown linking high levels of Cr 
VI exposure with decreased fetal weight, internal and skeletal abnormalities, and delayed 
maturation of offspring.  Chromium is capable of being transferred from the mother to the fetus 
via the placenta and to an infant via breast milk (Public Health Service, 2012). 
There also is a lack of studies and little evidence or data that supports any greater effects 
of Cr VI exposure to children as compared to adults (Public Health Service, 2012).  However, 
other developmental factors such as diet, living environment, and the natural progression of their 
physiological development may result in some variation in toxicological susceptibility (U.S. 
Environmental Protection Agency, 1998).  Children, however, are more susceptible to 
unintended ingestion or dermal contact with objects that may potentially contain Cr VI (such as 
contaminated soil).  Because most child exposures to Cr VI occur from accidental (and often 
fatal) ingestion of Cr VI compounds limited data sets exist.  This evidence is similar to 
symptoms observed in adults (Public Health Service, 2012). 
Individuals living near chromium-related production, manufacturing, and disposal sites 
have the potential for increased exposures to higher levels of Cr VI than the average individual.  
These elevated exposure levels included airborne Cr VI in the forms of aerosols and particulates, 
contaminated soil, and potable water sources used for drinking and bathing (Public Health 
Service, 2012). 
Workers in industrial settings that utilize chromium containing compounds in any process 
or step are at the greatest risk Cr VI exposure.  These groups can have exposure levels up to two 
orders of magnitude higher than the general population.  As mentioned previously, high levels of 
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Cr VI exposure can potentially occur in workplaces with processes involving electroplating 
(chrome plating), welding, painting, paint removal, production of pigments, Portland cement, 
iron, steel, and alloy production.  In some studies of these industries, little or no control measures 
were in place to prevent or reduce Cr VI exposure.  In other cases, where mitigation and controls 
measures were in place, some samples evaluated were above NIOSH RELs.   
When painting whole aircraft of large aircraft parts, it can be difficult to control Cr VI 
exposures during the spray application of paints and coatings without the use of PPE.  A French 
study of the aeronautics painting sector (which included stripping and touchup operations) found 
that 58.4% of workers were exposed to Cr VI at levels greater than 1 µg/m3.  (Vincent, et al., 
2015)  An advanced analysis of previously monitored chromate workers estimated that for Cr VI 
exposures at a level of 0.10 mg/m3, there is a lifetime excess risk of lung cancer related death of 
1 in 10 (Park, et al., 2004).  A long term cohort study of nearly 500 chromate production workers 
found increaed rates of mortality due to lung cancer for groups with cumulative Cr VI exposure 
in excess of 1.05 mg/m3-years.  These studies highlight the importance of evaluating and 
establishing multi-layered control systems to reduce Cr VI exposure levels (L.M. Blade, 2007). 
2.10. Report Objectives 
The goal of this study was to investigate occupational exposures to Cr VI, via inhalation, 
during tasks associated with corrosion control for military aircraft. Sample results for three 
primary tasks, abrasive blasting, sanding, and primer (paint) application, were obtained.  These 
results were evaluated to determine if the exposure distribution allowed for establishment of 
Similar Exposure Groups (SEGs) within the department.  The null hypothesis for this study was 
that mean exposures of each task are the same.   
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3. Methods and Measurement 
3.1. Sampling Demographic 
All samples were taken on civilian personnel assigned at a major military aircraft 
maintnance facility.  The personnel sampled are considered “painters” with varying levels of 
seniority and are assigned to five shops working in five separate buildings.  Three primary tasks - 
abrasive blasting, sanding, and primer (paint) application - are associated with corrosion control 
of the military aircraft serviced at this facility.  These tasks are performed on numerous types of 
helicopters (CH-53, SH-60, UH-1, etc.), airplanes (F/A-18, E-2, C-2, etc.) and the tiltrotor MV-
22.  The work is performed on full airframes as well as individual components (i.e. fuel tanks, 
rotodomes, etc.).  Commonalities among worker skill sets and work requirements result in 
personnel movement in and among the five separate shops. 
3.2. Process Description and Existing Controls 
3.2.1. Abrasive Blasting 
The abrasive blasting task is performed in specialized walk-in abrasive blasting 
enclosures that are equipped with dedicated ventilation systems.  Both Glass and plastic media 
are used in the removal of previously applied coatings depending on the scope of work involved.   
Personnel performing this task wear tight-fitting full facepiece, continuous flow, supplied air 
abrasive blast hoods, cloth or Tyvek coveralls/suits, leather (glass) or nitrile (plastic) gloves, and 
double hearing protection (ear plugs and ear muffs).  Figures 1, 2, and 3 show the abrasive 
blasting walk in enclosure, controls, and media reclamation system. 
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Figure 1: Abrasive Blasting Walk-In Booth 
 
 
Figure 2: Abrasive Blast Booth Control System 
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Figure 3: Abrasive Blast Media Reclamation System 
3.2.2. Sanding 
Pneumatic, orbital sanding of aircraft and aircraft components is conducted in the larger 
“paint bays”.  These spaces are equipped with a dedicated, cross-flow ventilation system that 
supports the entire space. Figures 4, 5, and 6 show the sanding/paint bay layout, controls, and 
exhaust location outside of the facility.  The normal operational mode of the ventilation system is 
“Position 1” which has all four supply fans and all four exhaust fans running at full speed 
providing the maximum flow rate.  Personnel performing this task wear tight-fitting full 
facepiece, continuous flow, supplied air respirators, cloth or Tyvek coveralls/suits, leather (glass) 
or nitrile (plastic) gloves, and double hearing protection (ear plugs and ear muffs).   
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Figure 4: Sanding/Painting Bay 
 
 
Figure 5: Sanding/Paint Bay Ventilation Modes 
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Figure 6: Sanding/Paint Bay Exhaust Ventilation 
 
3.2.3. Primer Application 
Two primer paints are utilized for the aircraft maintained at this facility.  Military 
specification MIL-PRF-85582 Type I (gloss) and Type II (flat) Class C1 paints are utilized on 
most aircraft surfaces and components.  Both contain types contain barium chromate.  MIL-PRF-
23377J Type 1 (gloss) Class C2 is utilized primarily on wheel assemblies and contains strontium 
chromate (Naval Air Systems Command, 2014).  Safety Data Sheets for these primers are 
included in Appendix B.  The paints are applied using High Volume Low Pressure (HVLP) spray 
guns operated at less than 10 psi.  Primer application is conducted in the same paint bays as the 
sanding task previously discussed.  The normal operational mode of the ventilation system is 
“Position 1” which has all four supply fans and all four exhaust fans running at full speed 
providing the maximum flow rate.  Personnel performing this task wear tight-fitting full 
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facepiece, continuous flow, supplied air respirators, Tyvek suits over cloth coveralls, and nitrile 
or latex gloves to control exposure during this phase. 
3.3. Sampling Method and Equipment 
Chromium VI exposure was assessed using individual air samples for the aircraft 
corrosion control tasks of abrasive blasting, sanding, and primer paint application.  Samples were 
obtained using Sensidyne Gillian 5000 or GilAir 5 air sampling pumps, using 37-mm, 5.0-µm 
polyvinyl chloride (PVC) filter cassettes, with calibration performed using Bios Defender 520 or 
TSI 4199 primary calibrators for the OSHA ID-215 Revision 2 method recommended sample 
flow rate of 2.0 L/min.  NIOSH Manual of Analytical Methods (NMAM) specifications also 
exist for chromium VI sampling.  NMAM method 7600 also requires 37-mm, 5.0-µm polyvinyl 
chloride (PVC) filter cassettes at flow rates of 1.0-4.0 L/min with minimum sample volumes of 
34-400 L.   
Air sampling was conducted by assigned Industrial Hygienists, Industrial Hygiene and 
Industrial Hygiene Technicians.  The air sampling pumps were secured to a belt on the worker’s 
back, connected to sampling cassettes with flexible tubing, and the cassettes were placed outside 
of the worker’s respirator but within the breathing zone on the shoulder of the individual’s 
dominant hand.  Samples were collected for the duration of the task type (i.e. abrasive blasting) 
for each individual’s work day.   
At the end of each working day, completed samples were driven to a local Industrial 
Hygiene Laboratory.  Lab samples were analyzed using the OSHA ID-215 Revision 2 method 
within the 14 day hold time and results were transmitted to Industrial Hygiene staff via email.  
Sample results were assessed by Industrial Hygienists and health risk exposure assessment 
reports generated for dissemination to facility supervisors and individuals.  Sample data (to 
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include pump sample train information) and results were entered into both an Excel data file as 
well as a health records database. 
3.4. Data Analysis 
The American Industrial Hygiene Association (AIHA) IHSTAT Excel program was 
utilized to provide statistical analysis and graphing of the collected exposure data.  Sample data 
was analyzed for all tasks combined and individually by each task (abrasive blasting, sanding, 
and primer paint application) to assess against the OSHA PEL and compare individual tasks.   
Sample results from the CIHL were given as Cr VI concentration in units of mg/m3. 
These values were converted to µg/m3 and 8-hour Time Weighted Averages (TWA) were 
calculated to assess results for overexposures to the OSHA PEL. 
Equation 1 - 8 hour TWA Calculation 
8-hour TWA (µg/m3) = sample concentration (µg/m3) * task duration (minutes) 
480 minutes 
(1) 
 In cases where laboratory results were less than the Limit of Quantification (LOQ) of 
0.05 µg, sample values were adjusted by dividing the concentration result by the square root of 
two. 
The goal of this study was to determine if means of Cr VI exposure among the three 
chosen tasks (abrasive blasting, sanding, and primer application) were equal such that the tasks 
could be combined into one SEG for exposure monitoring purposes.  Since more than two tasks 
are performed by this department, a one-way analysis of variance (ANOVA) statistical test was 
performed on the sample results to determine if the mean exposure among the three tasks was 
equal.  The null hypothesis for this study was that mean exposures of each task would be the 
same.  If the ANOVA test results indicated that the three means were not equal, a post-hoc 
30 
Tukey Honestly Significant Difference (HSD) process would be used to determine which pairs 
of tasks were significantly different. 
The AIHA IHSTAT Excel program was utilized to assess Cr VI overexposures with 
respect to the OSHA PEL, assess overall Cr VI exposure among the entire sample set, compare 
individual task sample groups, and evaluate the potential to use each task as separate SEGs. 
3.5. Limitations of Experiment 
Limitations of this experiment include those associated with the sampling method, 
sample analysis, number of samples obtained, and duration of each indiviudal sample. 
The OSHA ID-215 Revision 2 method has an analytical procedure detection limit of 
0.081 ng of Cr VI, an overall procedure detection limit of 0.80 ng/sample, a reliable quantitation 
limit of 2.67 ng/sample, an instrument calibration standard error of 0.404 ng/mL over a range of 
25-200 ng/mL (corresponding to 0.25-2.0 times the OSHA TWA), and an overall precision of 
10.0%.  (OSHA, 2017) The stated LOQ for the laboratory is 0.05 µg.  Each individual air sample 
was limited to the total time the worker spent on each singular task (abrasive blasting, sanding, 
or primer application).  In all 19 samples collected for this analysis, the total sample time was 
less than 8 hours or 480 minutes. 
 
4. Results 
4.1. Overall 
Chromium VI exposure for all tasks (N=19) (abrasive blasting N=7, sanding N=6, primer 
application N=6) ranged from 0.04 µg/m3 to 44.96 µg/m3 as shown in the sequential data plot in 
Figure 7.  The mean Cr VI exposure was 8.81 µg/m3. 
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Figure 7: - Sequential Data Plot with Individual Task Annotation 
 
Complete IHSTAT analysis for the overall sampling data is included in Appendix A.  
The IHSTAT analysis for the overall sample data indicated a lognormal distribution coefficient 
of 0.892 and normal distribution coefficient of 0.739 indicating the overall sample set better fits 
a lognormal distribution.  The geometric mean (GM) and geometric standard deviation (GSM) 
were 1.710 and 11.798 respectively.  A GSD of greater than 3.5 is indicative of high variability 
of the overall sample set (Jahn, 2015).  The 95th percentile value of 99% and exceedance fraction 
(percent above OEL) of 33% indicate overexposures among all three tasks are occuring and that 
the processes are not “in control”.  The overall sample data meets the criteria of a “clearly 
unacceptable exposure profile” (Hewett, 2005). 
Complete ANOVA analysis results determined from Excel are shown in Appendix A.  
The ANOVA results show an F ratio of 0.91 (less than the critical F value of 3.63) and a p-value 
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of 0.42 which is greater than the programmed significance level () of 0.05.  Therefore, we fail 
to reject the null hypothesis that the mean exposure levels of the three tasks combined are equal.  
Because the ANOVA test resulted in a p-value of greater than 0.05 and thus found no difference 
between tasks, evaluation for specific differences between tasks using a post-hoc Tukey HSD 
analysis would not be useful.   
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4.2. Abrasive Blasting 
Chromium VI exposure during abrasive blasting tasks (N=7) ranged from 0.04 µg/m3 to 
29.58 µg/m3 as shown in Table III.  The mean Cr VI exposure was 9.56 µg/m3. 
Table III: Abrasive Blasting Sample Results 
Sample ID 
Abrasive Blasting 
Task 
Calculated 
8-hour 
TWA 
(µg/m3) 
16-251 Various parts 22.11 
16-398 C-2 seat 29.58 
16-806 Various parts 5.38 
16-807 Various parts 2.65 
17-191 E-2 rotodome 0.37 
17-192 E-2 rotodome 0.37 
17-406 Various parts 7.08 
 
The IHSTAT analysis for the abrasive blasting task indicated a lognormal distribution 
coefficient of 0.820.  The geometric mean (GM) and geometric standard deviation (GSM) were 
1.894 and 16.806 respectively.  A GSD of greater than 3.5 indicates the abrasive blasting task is 
highly variable (Jahn, 2015).  The 95th percentile value of 196.5% and exceedance fraction 
(percent above OEL) of 36.545% indicate overexposures are occurring in the abrasive blasting 
task and the process is not “in control”.  Additionally, one abrasive task sample exceeded the 
OSHA aerospace industry PEL exception of 25 µg/m3.  The overall sample data meets the 
criteria of a “clearly unacceptable exposure profile” (Hewett, 2005). 
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4.3. Sanding 
Chromium VI exposure during sanding tasks (N=6) ranged from 0.04 µg/m3 to 11.5 
µg/m3 as shown in Table IV.  The mean Cr VI exposure was 3.53 µg/m3. 
Table IV: Sanding Sample Results 
Sample ID Sanding Task 
Calculated 
8-hour 
TWA 
(µg/m3) 
16-231 E-2 airframe 0.04 
16-385 SH-60 airframe 0.19 
16-733 F/A-18 airframe 0.04 
16-1292 F/A-18 airframe 0.44 
17-293 MV-22 airframe 9.00 
17-378 SH-60 airframe 11.50 
 
The IHSTAT analysis for the abrasive blasting task indicated a lognormal distribution 
coefficient of 0.879.  The geometric mean (GM) and geometric standard deviation (GSM) were 
0.479 and 12.835 respectively.  A GSD of greater than 3.5 indicates the abrasive blasting task is 
highly variable (Jahn, 2015).  The 95th percentile value of 31.9% and exceedance fraction 
(percent above OEL) of 17.9% indicate overexposures are occurring in the abrasive blasting task 
and the process is not “in control”.  The overall sample data meets the criteria of a “unacceptable 
exposure profile” (Hewett, 2005). 
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4.4. Primer Application 
Chromium VI exposure during primer application tasks (N=6) ranged from 0.85 µg/m3 to 
44.96 µg/m3 as shown in Table V.  The mean Cr VI exposure was 13.22 µg/m3. 
Table V: Primer Application Sample Results 
Sample ID 
Primer Application 
Task 
Calculated 
8-hour 
TWA 
(µg/m3) 
16-404 E-2 airframe 5.20 
16-441 Various parts 44.96 
16-986 E-2 rotodome 2.33 
16-1082 Various parts 2.30 
17-369 F/A-18 drop tanks 0.85 
17-403 Various parts 23.65 
 
The IHSTAT analysis for the abrasive blasting task indicated a lognormal distribution 
coefficient of 0.944.  The geometric mean (GM) and geometric standard deviation (GSM) were 
5.410 and 4.575 respectively.  A GSD of greater than 3.5 indicates the abrasive blasting task is 
highly variable (Jahn, 2015).  The 95th percentile value of 65.9% and exceedance fraction 
(percent above OEL) of 52.1% indicate overexposures are occurring in the abrasive blasting task 
and the process is not “in control”.  The overall sample data meets the criteria of a “clearly 
unacceptable exposure profile” (Hewett, 2005). 
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5. Discussion and Conclusions 
Chromium VI air sampling was conducted for three tasks associated with military aircraft 
corrosion control at the facility.  The mean exposures for the overall samples and each individual 
task exceeded the OSHA Action Limit (AL) of 2.5 µg/m3 and the PEL of 5 µg/m3 (except the 
sanding task).  Additionally, one abrasive task and one primer task exceeded the OSHA 
aerospace industry PEL exception of 25 µg/m3.  Without appropriate Personal Protective 
Equipment (PPE), personnel executing these tasks can expect to be overexposed to Cr VI.   
Current respiratory protection used by personnel performing these tasks are tight-fitting 
full facepiece, continuous flow, supplied air respirators or combination abrasive blast 
hood/respirator with Assigned Protection Factors (APF) of 1,000.  The Maximum Use 
Concentration (MUC) of these respirators well exceeded the highest observed sample exposures 
for each task. 
A high degree of variability was observed in the overall sample set and the individual 
tasks.  IHSTAT analysis of the overall sample set failed to resolve for a lognormal or normal 
distribution, but most closely correlated to a lognormal distribution.   Each individual task 
resolved to a lognormal distribition.  
The one-way ANOVA analysis indicated that the null hypothesis that all task mean 
exposures were equal could not be rejected.  Failure to reject the null hypothesis was caused by 
the high degree of variability among the tasks coupled with the small differences in means.  Each 
task had two individual samples that significantly deviated from the remainder of the sample set 
that may have also contributed to the ANOVA analysis failing to identify separate SEGs.  
Despite the inability to perform a Tukey HSD post-hoc analysis based on the ANOVA results, a 
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Tukey analysis is included in Appendix B for reference should further data be obtained or 
additional research be conducted. 
All personnel within the department should understand that there exists a high probability 
of overexposure regardless of the task conducted.  All personnel should also be trained on the 
proper function, fitting, and use of existing PPE and exhaust ventilation systems.  
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6. Recommendations for Further Research 
The inability to reject the null hypothesis based on ANOVA analysis coupled with 
several “peak” sample results indicate further analysis is required of the corrosion control tasks 
at this facility.  Additional follow-on samples or a larger original sample size may mitigate the 
effect of these peaks in similar future studies. 
Additionally, many different airframe and component types were processed during the 
oberved sampling period.  An insufficient number of samples were obtained in order to perform 
further analysis to determine if overexposures or additional SEG refinement could be conducted 
on this basis.  Particularly noteworthy from this study were the overexposures observed in the 
sanding tasks performed on the MV-22 airframe.  Processing of this airframe is new to this 
facility.   Also this airframe has a higher percentage of composite materials (as compared to 
other aircraft) that do not require primers containing chromates.   
Exhaust ventilation systems in each of the buildings were assumed to be in operation and 
functioning according to design specifications during sampling evolutions.  Further studies 
should include a check or field note regarding presence and operation of these systems.   
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Appendix A: IHSTAT and ANOVA analysis 
Excel ANOVA Analysis 
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IHSTAT Analyses 
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Appendix B: Safety Data Sheets and Tukey Analysis 
MIL-PRF-85582 Type I Class 1 Primer MSDS 
*** Emergency Overview ***:  Flammable liquid and vapors. Harmful by inhalation, in contact with skin, 
and if swallowed. Contact with eyes or skin causes irritation. 
Effects Of Overexposure - Eye Contact:   Exposure to liquid, aerosol, or vapors may cause irritation, 
tearing, redness, and swelling accompanied by a stinging sensation. Contact with eyes may cause 
blurred vision and irritation. 
Effects Of Overexposure - Skin Contact:   Direct skin contact may cause irritation. Symptoms may 
include swelling, burning, redness, itching, and rash. Prolonged or repeated skin contact may cause 
dermatitis, drying, and defatting due to the solvent properties. May cause allergic skin reaction. May 
cause severe skin irritation. It is possible for one of the components to pass through the skin, and the 
component may add to the toxic effects of either ingestion or inhalation. 
Effects Of Overexposure - Inhalation:   Inhalation may cause irritation to the respiratory tract (nose, 
mouth, mucous membranes) & acute nervous system depression characterized by the following 
progressive steps: headache, nausea, weakness, dizziness, staggering gait, confusion, fatigue, 
drowsiness, unconsciousness, or coma. Exposure may cause a sore throat, runny nose, difficult 
breathing, shortness of breath, or coughing. Inhalation of decomposition products in high concentration 
may cause shortness of breath (lung edema). Inhalation may cause headaches, difficult breathing, and 
loss of consciousness. A component maybe harmful if inhaled. 
Effects Of Overexposure - Ingestion:   Ingestion may cause irritation to mucous membranes. May 
result in possible corrosive action in the mouth, stomach tissue, and digestive tract. Vomiting may cause 
aspiration of the solvent, resulting in chemical pneumonitis. Ingestion may cause nausea, vomiting, 
abdominal pain, and diarrhea. Ingestion may cause nervous system effects, which may include 
headache, dizziness, numbness, staggering gait, or confusion. 
Effects Of Overexposure - Chronic Hazards:  Prolonged contact will cause drying and cracking of the 
skin, due to defatting action. Skin sensitization, asthma, or other allergic responses may develop. Kidney 
and liver damage may occur from prolonged or repeated overexposures. Repeated and prolonged 
exposure may cause delayed effects involving the blood, gastrointestinal, nervous, and reproductive 
systems. Exposure to a component may cause kidney damage, coma, difficult breathing, liver damage, 
blood abnormalities (breakage of red blood cells), blood in the urine, or death. 
Primary Route(s) Of Entry:  Skin Contact, Inhalation, Eye Contact 
Material Safety Data Sheet 
For Coatings, Resins and Related Materials 
NOTE:   CHEMTREC, CANUTEC and National Response Center emergency numbers to be used only in the event of 
chemical emergencies involving a spill, leak, fire, exposure or accident involving chemicals 
24 Hour Emergency:  1-800-123-4567 CHEMTREC:  1-800-424-9300
National Response in Canada  CANUTEC:  613-996-6666 
Outside U.S. and Canada  Chemtrec:   202-483-7616 
Section 1 - Chemical Product / Company Information
Product Name: MIL-PRF-85582D-TYPE I-CLASS C1 
BASE Revision Date: 06/21/2011
Identification 
Number: 44GN007 Print Date:
Product Use/Class: 
EPOXY PRIMER BASE 
COMPONENT/MIL-PRF-85582, TYPE 
I, CLASS C1 (BARIUM CHROMATE) 
NSN: 
Manufacturer: Deft, Inc.  (CAGE CODE 33461) 
17451 Von Karman Ave 
Irvine, Ca.  92614 
Information Phone: 
Emergency Phone: 
(949) 474-0400
(800) 424-9300 
Section 2 - Hazards Identification
Section 3 - Composition / Information On Ingredients 
Component CAS Number Weight % Reporting Ranges
BARIUM CHROMATE 10294-40-3 10-30
2-BUTOXYETHANOL 111-76-2 10-30
TITANIUM DIOXIDE 13463-67-7 5-10
AROMATIC HYDROCARBON 64742-95-6 5-10
1,2,4 TRIMETHYLBENZENE 95-63-6 3-7
BISPHENOL A EPOXY RESIN, AVG. MOL. WT. < 700 25085-99-8 1-5
Page 1 of 5MSDS Number: 44GN007 MIL-PRF-85582D-TYPE I-CLASS C1 BASE
7/21/2011file://C:\Program Files\ProductVision 4.5\REPORTS\~PV87805.htm
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ALL INGREDIENTS ARE ON THE TSCA INVENTORY LIST, UNLESS OTHERWISE NOTED IN SECTION 
8. 
  
First Aid - Eye Contact:  If material gets into eyes, flush with water immediately for 15 minutes. Hold 
eyelids open to rinse out the entire eye. Consult a physician. If symptoms develop from airborne 
exposure, move to fresh air. 
First Aid - Skin Contact:  Remove contaminated clothing and shoes. In case of contact, immediately 
flush skin with plenty of water and wash affected areas thoroughly with soap and water for at least 15 
minutes. If symptoms develop (such as irritation), consult a physician or get medical attention. Wash 
contaminated clothing thoroughly before reuse or discard. 
First Aid - Inhalation:  Move to fresh air in case of accidental inhalation of vapors. Give oxygen or 
artificial respiration if needed. Asthmatic type symptoms may develop and maybe immediate or delayed 
by several hours. In the case of inhalation of aerosol/mist, consult a physician, if necessary. 
First Aid - Ingestion:  Do not induce vomiting. Never give anything by mouth to an unconscious person. 
Consult a physician. 
Extinguishing Media: Carbon Dioxide, Dry Chemical, Foam, Water Spray, Dry Sand, Dry Powder 
Unusual Fire And Explosion Hazards: Keep containers tightly closed. Isolate from heat, sparks, electrical 
equipment and open flame. Closed containers may burst if exposed to extreme heat or fire. Application to 
hot surfaces requires special precautions. Toxic gases may form when product burns. Vapors are heavier 
than air and may travel/spread along the floors/ground. Vapors may flow along surfaces or they can be 
moved by ventilation, to a distant source of ignition. Do not use a cutting or welding torch near or on a 
drum of product, because vapors may ignite explosively, even if the drum is empty and contains only 
product residue. Peroxides of unknown stability and that are explosive may form. 
Special Firefighting Procedures: In the event of fire, wear self-contained breathing apparatus. Firefighters 
should wear full protective clothing. In the event of fire, cool tanks with water spray. 
Steps To Be Taken If Material Is Released Or Spilled: Evacuate all non-essential personnel. Remove all 
sources of ignition. Ventilate area. Contain and remove spilled material with inert absorbent and non-
sparking tools. Dispose of as hazardous waste. Dike to prevent entering any sewer or waterway. Soak up 
with vermiculite or inert absorbent material and dispose of as hazardous waste. Only trained personnel 
wearing protective equipment should handle spill cleanup. Avoid personal contact. 
Handling: Prevent prolonged breathing of vapors or spray mist. Avoid contact with eyes and skin. Do not 
take internally. Do not handle until the manufacturers safety precautions have been read and understood. 
Handle in accordance with good industrial hygiene and safety practice. Keep away from heat and 
sources of ignition. Use safety precautions with empty containers. Empty containers may contain 
hazardous materials (product residues) in the form of solids, liquids, or vapors. Always use grounding 
leads when transferring from one container to another. 
Storage: Store in buildings designed to comply with OSHA 1910.106. Avoid storing near high 
temperatures, fire, open flames, and spark sources. Keep containers upright to prevent leakage and 
tightly closed in a dry, cool, and well-ventilated place. Protect material from direct sunlight. 
  
Section 4 - First Aid Measures 
Section 5 - Fire Fighting Measures
Flash Point (°F): 116 TCC LOWER EXPLOSIVE LIMIT 
(%): 1.0 
UPPER EXPLOSIVE LIMIT (%): 10. 
Section 6 – Accidental Release Measures
Section 7 - Handling and Storage
Section 8 - Exposure Controls / Personal Protection
Component ACGIH TLV ACGIH STEL OSHA PEL OSHA STEL
BARIUM CHROMATE N.E. 5 ug/m3 Cr(+6) N.E.
2-BUTOXYETHANOL 25 ppm N.E. 25 ppm N.E.
TITANIUM DIOXIDE 10 mg/m3 N.E. 15 mg/m3 N.E.
AROMATIC HYDROCARBON 100 ppm N.E. N.E. N.E.
1,2,4 TRIMETHYLBENZENE 25 ppm 150 mg/m3 100 ppm N.E.
BISPHENOL A EPOXY RESIN, 
AVG. MOL. WT. < 700
Notes
BARIUM CHROMATE CAS# 10294-40-3 - Contains 20.5 weight % Hexavalent Chromium. IARC Group 1 carcinogenic to humans. NTP 
group 1 known carcinogen. ACGIH category A2 (2002) suspected human carcinogen. Inhalation of 30 mg/m3 of Hexavalent Chromium is 
immediately dangerous to life or health. Ingestion of high concentration may cause intense thirst, shock, dizziness, oliguria, severe 
circulatory collapse, vomiting, anuria, or abdominal pain. Death may occur due to uremia. Ingestion in one uptake of approximately 1-16 g 
Page 2 of 5MSDS Number: 44GN007 MIL-PRF-85582D-TYPE I-CLASS C1 BASE
7/21/2011file://C:\Program Files\ProductVision 4.5\REPORTS\~PV87805.htm
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Engineering Controls: Local ventilation of emission sources may be necessary to maintain ambient 
concentrations below permissible OSHA exposure limits. Remove all ignition sources (heat, sparks, 
flame, and hot surfaces). 
Respiratory Protection: A respirator that is recommended or approved for use in an organic vapor 
environment (air purifying or fresh air supplied) is necessary. Observe OSHA regulations for respirator 
use. Ventilation should be provided to keep exposure levels below the OSHA permissible limits. 
Skin Protection: Solvent-resistant gloves. 
Eye Protection: Wear safety eyewear (safety glasses, safety glasses with side-shields, chemical goggles, 
or face shields) to prevent eye contact. 
Other protective equipment: Long sleeve and long leg clothing is recommended. Remove and wash 
contaminated clothing before reuse or discard. Wear boots that are chemical-resistant. 
Hygienic Practices: Wash hands before breaks, eating, smoking, using washroom, and at the end of the 
workday. 
(See section 16 for abbreviation legend) 
Conditions To Avoid: Avoid high temperatures. Epoxy resins under uncontrolled conditions. Do not 
breathe vapors or spray mist. 
Incompatibility: Material is incompatible (reacts) with oxidizing agents (strong oxidizers), strong acids 
(including exothermic reactions with strong acids), strong alkalis, strong reducing agents, epoxy resins, 
isocyanate functional materials, heat, aluminum, and salts of strong bases. Material is incompatible with 
oxidizing agents. Material is incompatible with acids and bases. Reacts with amines and mercaptans. 
Hazardous Decomposition: Thermal decomposition can lead to the generation and release of gases and 
vapors including carbon monoxide, carbon dioxide, and oxides of nitrogen. Chromium oxides when 
burned. Thermal decomposition may generate irritating gases and vapors. Ketones, organic acids, and 
aldehydes may form. 
Hazardous Polymerization: Polymerization may occur. 
Stability: Stable under recommended storage conditions. 
Ecological Information: No Information. 
Disposal Information: Dispose of waste in accordance with federal, state, and local environmental 
regulations. Empty containers will contain product residue and flammable vapors. Handle as hazardous 
material. Do not incinerate closed containers. EPA Hazardous Waste Number/Code: D001, D007. 
Hazardous Waste Characteristics: Ignitability. 
can be lethal to humans.
2-BUTYOXYETHANOL CAS# 111-76-2 - This component has been shown to cause harm to the fetus in laboratory animals. It only caused 
harm at levels of overexposure that would also harm the pregnant animal. It has been shown to cause cancer in laboratory animals. The 
relevance to humans is unknown. It also has been shown to cause reversible kidney effects, reversible liver effects, and blood abnormalities
in laboratory animals. Congestion in the spleen, liver, kidneys, and lungs resulted from acute lethal exposure in animal studies.
TITANIUM DIOXIDE CAS# 13463-67-7 - ACGIH/TLV & OSHA/PEL exposure limits are for the total dust. IARC Group 2B possibly 
carcinogenic to humans. Titanium Dioxide is considered by NIOSH to be a potential occupational carcinogen under Hazard Communication 
Standard, 29 CFR 1910.1200. This was based on NIOSH's interpretation of the study by Lee, Trochimowicz, and Reinhardt [1985], 
"Pulmonary Response of Rats Exposed to Titanium Dioxide (TiO2) by Inhalation for Two Years." "The authors of this study concluded that 
based on the excessive dust loading and overwhelmed clearance mechanism in the lungs of rats exposed chronically at 250 mg/m3 (6 
hrs/day, 5 days/week for 2 years), the biological relevance of lung tumors to man appears to be negligible."
 Section 9 - Physical and Chemical Properties
Boiling Range (°F): 308 - 343  Vapor Density: > 1 (AIR = 1)
Odor:  2-BUTOXYETHANOL & 
AROMATIC HYDROCARBON 
SOLVENTS 
Odor Threshold: N.D. 
Appearance:  Green liquid Evaporation Rate: ND 
Solubility in H2O:  ND   
Freeze Point:  N.D. Specific Gravity: 1.520 
Vapor Pressure, mm Hg:  3.6 PH: N.A. 
Physical State:  Liquid Viscosity: > 18 #2 ZAHN CUP 
SECONDS
 Section 10 - Stability and Reactivity
 Section 11 - Toxicological Information
Product LD50: N.E. Product LC50: N.E.
Section 12 - Ecological Information 
Section 13 - Disposal Information 
Section 14 - Transportation Information
DOT Proper Shipping Name: Paint Packing Group: III 
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CERCLA – SARA Hazard Category 
This product has been reviewed according to the EPA ‘Hazard Categories’ promulgated under Sections 
311and 312 of the Superfund Amendment and Reauthorization Act of 1986 (SARA Title III) and is 
considered, under applicable definitions, to meet the following categories:  IMMEDIATE HEALTH 
HAZARD, CHRONIC HEALTH HAZARD, FIRE HAZARD 
  
SARA Section 313: 
This product contains the following substances subject to the reporting requirements of Section 313 of 
Title III of the Superfund Amendment and Reauthorization Act of 1986 and 40 CFR part 372: 
  
Toxic Substances Control Act: 
This product contains the following chemical substances subject to the reporting requirements of TSCA 
12(B) if exported from the United States: 
  
U.S. State Regulations: As follows – 
New Jersey Right-to-Know: 
The following materials are non-hazardous, but are among the top five components in this product.  
  
 Pennsylvania Right-to-Know: 
The following non-hazardous ingredients are present in the product at greater than 3%. 
  
California Proposition 65:  
Warning: The following ingredients present in the product are known to the state of California to cause 
Cancer: 
  
Warning: The following ingredients present in the product are known to the state of California to cause 
birth defects, or other reproductive hazards. 
  
International Regulations: As follows – 
CANADIAN WHMIS:  This MSDS has been prepared in compliance with Controlled Product Regulations 
except for the use of the 16 headings. 
CANADIAN WHMIS CLASS: B2, D1A, D2A, D2B 
  
  
NFPA Fire Rating: 2 
DOT Technical Name: N.A. Hazard Subclass: N.A. 
DOT Hazard Class: FLAMMABLE LIQUID 3 Resp. Guide Page: N.A. 
DOT UN/NA Number: UN-1263 IATA: REGULATED
Section 15 - Regulatory Information
Component CAS Number Percent By Weight
BARIUM CHROMATE 10294-40-3 23.0360
2-BUTOXYETHANOL 111-76-2 13.2399
1,2,4 TRIMETHYLBENZENE 95-63-6 4.2413
Component CAS Number
ZINC CHROMATE 11103-86-9
Component CAS Number
MAGNESIUM SILICATE 14807-96-6
POLYAMIDE RESIN 68082-29-1
Component CAS Number
MAGNESIUM SILICATE 14807-96-6
POLYAMIDE RESIN 68082-29-1
Component CAS Number Percent By Weight
BARIUM CHROMATE 10294-40-3 23.0360
CUMENE (ISOPROPYL BENZENE) 98-82-8 0.3938
SILICA, CRYSTALLINE (QUARTZ) 14808-60-7 0.0623
STRONTIUM CHROMATE 7789-06-2 0.0231
ZINC CHROMATE 11103-86-9 0.0231
Component CAS Number Percent By Weight
BARIUM CHROMATE 10294-40-3 23.0360
STRONTIUM CHROMATE 7789-06-2 0.0231
ZINC CHROMATE 11103-86-9 0.0231
Section 16 - Other Information 
HMIS Ratings:   
Health: 2 Flammability: 2 Reactivity: 0 Personal Protection: G
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NFPA Health Rating: 2 
NFPA Specific Hazard Rating: ND 
NFPA Stability Rating: 1 
  
VOLATILE ORGANIC COMPOUNDS, GR/LTR: 390 
VOLATILE ORGANIC COMPOUNDS, LB/GAL: 3.25 
VOLATILE ORGANIC COMPOUNDS MIXED, GR/LTR: <= 340 
VOLATILE ORGANIC COMPOUNDS MIXED, LB/GAL: <= 2.83 
VOLATILE ORGANIC COMPOUNDS, LB/LB-SOLID: <= 0.34 
VOLATILE ORGANIC COMPOUNDS OF MATERIAL (SCAQMD RULE 443.1), GR/LTR:  390 
VOLATILE ORGANIC COMPOUNDS OF MATERIAL (SCAQMD RULE 443.1), LB/GAL:  3.25 
VOLATILE HAPs PER WEIGHT SOLIDS, LB./LB.  0.00733 
REASON FOR REVISION: ADDED NSN TO FORMAT 
REGULATORY CODE: 44GN007 
LAYOUT CODE: A2004R 
Legend:  N.A. - Not Applicable, N.E. - Not Established, N.D. - Not Determined 
The information contained on this MSDS has been checked and should be accurate.  However, it is the 
responsibility of the user to comply with all Federal, State, and Local laws and regulations. 
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MIL-PRF-85582 Type II Class C1 primer SDS 
513X419 BASE COMPONENT
Not available.
Liquid.
SAFETY DATA SHEET
Product name
Other means of 
identification
Product type
Section 1. Identification
:
:
:
Product code : 513X419 BASE COMPONENT
Date of issue/Date of revision 28 January 2017
Version 11
Relevant identified uses of the substance or mixture and uses advised against
Uses advised against Not applicable.
Product use : Industrial applications.
Use of the substance/
mixture
: Coating.
:
Manufacturer PPG Aerospace PRC-DeSoto
12780 San Fernando Road
Sylmar, CA 91342
Phone:  818 362 6711
(412) 434-4515 (U.S.)
(514) 645-1320 (Canada)
01-800-00-21-400 (Mexico)
Emergency telephone 
number
:
:
Section 2. Hazards identification
FLAMMABLE LIQUIDS - Category 2
ACUTE TOXICITY (oral) - Category 4
ACUTE TOXICITY (inhalation) - Category 4
SKIN IRRITATION - Category 2
SERIOUS EYE DAMAGE - Category 1
SKIN SENSITIZATION - Category 1
CARCINOGENICITY - Category 1A
TOXIC TO REPRODUCTION (Unborn child) - Category 2
SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) - Category 1
Classification of the 
substance or mixture
:
GHS label elements
Percentage of the mixture consisting of ingredient(s) of unknown toxicity: 42%
OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard 
(29 CFR 1910.1200).
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Section 2. Hazards identification
Signal word : Danger
Hazard statements : Highly flammable liquid and vapor.
Harmful if swallowed or if inhaled.
Causes serious eye damage.
Causes skin irritation.
May cause an allergic skin reaction.
May cause cancer.
Suspected of damaging the unborn child.
Causes damage to organs through prolonged or repeated exposure.
Hazard pictograms :
Precautionary statements
Prevention : Obtain special instructions before use.  Do not handle until all safety precautions have 
been read and understood.  Wear protective gloves.  Wear eye or face protection.
Wear protective clothing.  Keep away from heat, hot surfaces, sparks, open flames and 
other ignition sources. No smoking.  Use explosion-proof electrical, ventilating, lighting 
and all material-handling equipment.  Use only non-sparking tools.  Take precautionary 
measures against static discharge.  Keep container tightly closed.  Use only outdoors or 
in a well-ventilated area.  Do not breathe vapor.  Do not eat, drink or smoke when using 
this product.  Wash hands thoroughly after handling.  Contaminated work clothing must 
not be allowed out of the workplace.
Response : Get medical attention if you feel unwell.  IF exposed or concerned:  Get medical 
attention.  IF INHALED:  Remove person to fresh air and keep comfortable for breathing.
Call a POISON CENTER or physician if you feel unwell.  IF SWALLOWED:  Call a 
POISON CENTER or physician if you feel unwell.  Rinse mouth.  IF ON SKIN (or hair):
Take off immediately all contaminated clothing.  Rinse skin with water or shower.  IF ON 
SKIN:  Wash with plenty of soap and water.  Wash contaminated clothing before reuse.
If skin irritation or rash occurs:  Get medical attention.  IF IN EYES:  Rinse cautiously 
with water for several minutes.  Remove contact lenses, if present and easy to do.
Continue rinsing.  Immediately call a POISON CENTER or physician.
Storage : Store locked up.  Store in a well-ventilated place.  Keep cool.
Disposal : Dispose of contents and container in accordance with all local, regional, national and 
international regulations.
Supplemental label 
elements
: Sanding and grinding dusts may be harmful if inhaled. This product contains crystalline 
silica which can cause lung cancer or silicosis.  The risk of cancer depends on the 
duration and level of exposure to dust from sanding surfaces or mist from spray 
applications. Trimethoxysilanes are capable of forming methanol if hydrolyzed or 
ingested. If swallowed, methanol may be harmful or fatal or cause blindness. Repeated 
exposure to high vapor concentrations may cause irritation of the respiratory system 
and permanent brain and nervous system damage. Inhalation of vapor/aerosol 
concentrations above the recommended exposure limits causes headaches,
drowsiness and nausea and may lead to unconsciousness or death. This product either 
contains formaldehyde or is capable of releasing formaldehyde above 0.5 ppm under 
certain conditions. Formaldehyde is a known cancer hazard, a skin sensitizer and a 
respiratory sensitizer. NTP, IARC and OSHA have classified chromium (+6) compounds 
as carcinogenic. Avoid contact with skin and clothing. Wash thoroughly after handling.
Emits toxic fumes when heated.
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Section 2. Hazards identification
Hazards not otherwise 
classified
: Prolonged or repeated contact may dry skin and cause irritation.
Section 3. Composition/information on ingredients
strontium chromate ≥20 - ≥50 7789-06-2
Formaldehyde, oligomeric reaction products with 1-chloro-2,3-epoxypropane 
and phenol
≥20 - ≥50 9003-36-5
crystaline silica, respirable powder (<10 microns) ≥10 - ≥20 14808-60-7
heptan-2-one ≥5.0 - ≥10 110-43-0
4-methylpentan-2-one ≥5.0 - ≥7.3 108-10-1
cristobalite (<10 microns) ≥1.0 - ≥5.0 14464-46-1
titanium dioxide ≥1.0 - ≥5.0 13463-67-7
cyclohexanone ≥1.0 - ≥5.0 108-94-1
toluene ≥1.0 - ≥4.9 108-88-3
butanone ≥1.0 - ≥4.3 78-93-3
[3-(2,3-epoxypropoxy)propyl]trimethoxysilane ≥1.0 - ≥5.0 2530-83-8
ethylbenzene <1.0 100-41-4
Ingredient name CAS number%
There are no additional ingredients present which, within the current knowledge of the supplier and in the 
concentrations applicable, are classified as hazardous to health or the environment and hence require reporting 
in this section.
Substance/mixture :
Occupational exposure limits, if available, are listed in Section 8.
Mixture
Any concentration shown as a range is to protect confidentiality or is due to batch variation.
Product name 513X419 BASE COMPONENT:
SUB codes represent substances without registered CAS Numbers.
Section 4. First aid measures
Eye contact
Skin contact
Inhalation
Ingestion :
:
:
:
Description of necessary first aid measures
Most important symptoms/effects, acute and delayed
:Eye contact
Potential acute health effects
If ingestion, irritation, any type of overexposure or symptoms of overexposure occur during or persists after use of 
this product, contact a POISON CONTROL CENTER, EMERGENCY ROOM OR PHYSICIAN immediately; have 
Safety Data Sheet information available. Never give anything by mouth to an unconscious or convulsing person.
Check for and remove any contact lenses. Immediately flush eyes with running water for 
at least 15 minutes, keeping eyelids open. Seek immediate medical attention.
Remove to fresh air. Keep person warm and at rest. If not breathing, if breathing is 
irregular or if respiratory arrest occurs, provide artificial respiration or oxygen by trained 
personnel.
Remove contaminated clothing and shoes. Wash skin thoroughly with soap and water 
or use recognized skin cleanser. Do NOT use solvents or thinners.
If swalowed, seek medical advice immediately and show this container or label. Keep 
person warm and at rest. Do NOT induce vomiting.
Causes serious eye damage.
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Section 4. First aid measures
Protection of first-aiders : No action shall be taken involving any personal risk or without suitable training.  If it is 
suspected that fumes are still present, the rescuer should wear an appropriate mask or 
self-contained breathing apparatus.  It may be dangerous to the person providing aid to 
give mouth-to-mouth resuscitation.  Wash contaminated clothing thoroughly with water 
before removing it, or wear gloves.
Notes to physician : Treat symptomatically.  Contact poison treatment specialist immediately if large 
quantities have been ingested or inhaled.
Specific treatments : No specific treatment.
Inhalation :
:Ingestion
Skin contact :
Over-exposure signs/symptoms
Skin contact
Ingestion
Inhalation Adverse symptoms may include the following:
reduced fetal weight
increase in fetal deaths
skeletal malformations
Adverse symptoms may include the following:
stomach pains
reduced fetal weight
increase in fetal deaths
skeletal malformations
Adverse symptoms may include the following:
pain or irritation
redness
dryness
cracking
blistering may occur
reduced fetal weight
increase in fetal deaths
skeletal malformations
:
:
:
Eye contact : Adverse symptoms may include the following:
pain
watering
redness
See toxicological information (Section 11)
Indication of immediate medical attention and special treatment needed, if necessary
Harmful if inhaled.
Harmful if swallowed.
Causes skin irritation.  Defatting to the skin.  May cause an allergic skin reaction.
Section 5. Fire-fighting measures
Use dry chemical, CO≥, water spray (fog) or foam.
Extinguishing media
Do not use water jet.
Suitable extinguishing 
media
:
Unsuitable extinguishing 
media
:
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Section 5. Fire-fighting measures
Promptly isolate the scene by removing all persons from the vicinity of the incident if 
there is a fire.  No action shall be taken involving any personal risk or without suitable 
training.  Move containers from fire area if this can be done without risk.  Use water 
spray to keep fire-exposed containers cool.
Hazardous thermal 
decomposition products
Specific hazards arising 
from the chemical
Decomposition products may include the following materials:
carbon oxides
halogenated compounds
metal oxide/oxides
Formaldehyde.
Highly flammable liquid and vapor.  In a fire or if heated, a pressure increase will occur 
and the container may burst, with the risk of a subsequent explosion.  Vapors may 
accumulate in low or confined areas or travel a considerable distance to a source of 
ignition and flash back.  Runoff to sewer may create fire or explosion hazard.  This 
material is very toxic to aquatic life with long lasting effects.  Fire water contaminated 
with this material must be contained and prevented from being discharged to any 
waterway, sewer or drain.
Fire-fighters should wear appropriate protective equipment and self-contained breathing 
apparatus (SCBA) with a full face-piece operated in positive pressure mode.
Special protective 
equipment for fire-fighters
:
:
:
Special protective actions 
for fire-fighters
:
Section 6. Accidental release measures
Environmental precautions
Personal precautions, protective equipment and emergency procedures
:
: No action shall be taken involving any personal risk or without suitable training.
Evacuate surrounding areas.  Keep unnecessary and unprotected personnel from 
entering.  Do not touch or walk through spilled material.  Shut off all ignition sources.
No flares, smoking or flames in hazard area.  Do not breathe vapor or mist.  Provide 
adequate ventilation.  Wear appropriate respirator when ventilation is inadequate.  Put 
on appropriate personal protective equipment.
Avoid dispersal of spilled material and runoff and contact with soil, waterways, drains 
and sewers.  Inform the relevant authorities if the product has caused environmental 
pollution (sewers, waterways, soil or air).
Stop leak if without risk.  Move containers from spill area.  Use spark-proof tools and 
explosion-proof equipment.  Dilute with water and mop up if water-soluble.  Alternatively,
or if water-insoluble, absorb with an inert dry material and place in an appropriate waste 
disposal container.  Dispose of via a licensed waste disposal contractor.
Small spill :
Methods and materials for containment and cleaning up
For non-emergency 
personnel
For emergency responders : If specialized clothing is required to deal with the spillage, take note of any information in 
Section 8 on suitable and unsuitable materials.  See also the information in "For non-
emergency personnel".
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Section 6. Accidental release measures
Stop leak if without risk.  Move containers from spill area.  Use spark-proof tools and 
explosion-proof equipment.  Approach release from upwind.  Prevent entry into sewers,
water courses, basements or confined areas.  Wash spillages into an effluent treatment 
plant or proceed as follows.  Contain and collect spillage with non-combustible,
absorbent material e.g. sand, earth, vermiculite or diatomaceous earth and place in 
container for disposal according to local regulations (see Section 13).  Dispose of via a 
licensed waste disposal contractor.  Contaminated absorbent material may pose the 
same hazard as the spilled product.  Note: see Section 1 for emergency contact 
information and Section 13 for waste disposal.
Large spill :
Section 7. Handling and storage
Advice on general 
occupational hygiene
Conditions for safe storage,
including any 
incompatibilities
Eating, drinking and smoking should be prohibited in areas where this material is 
handled, stored and processed.  Workers should wash hands and face before eating,
drinking and smoking.  Remove contaminated clothing and protective equipment before 
entering eating areas.  See also Section 8 for additional information on hygiene 
measures.
Do not store above the following temperature: 35°C (95°F).  Store in accordance with 
local regulations.  Store in a segregated and approved area.  Store in original container 
protected from direct sunlight in a dry, cool and well-ventilated area, away from 
incompatible materials (see Section 10) and food and drink.  Store locked up.  Eliminate 
all ignition sources.  Separate from oxidizing materials.  Keep container tightly closed 
and sealed until ready for use.  Containers that have been opened must be carefully 
resealed and kept upright to prevent leakage.  Do not store in unlabeled containers.
Use appropriate containment to avoid environmental contamination.
:
:
Protective measures Put on appropriate personal protective equipment (see Section 8).  Persons with a 
history of skin sensitization problems should not be employed in any process in which 
this product is used.  Avoid exposure - obtain special instructions before use.  Avoid 
exposure during pregnancy.  Do not handle until all safety precautions have been read 
and understood.  Do not get in eyes or on skin or clothing.  Do not breathe vapor or mist.
Do not ingest.  Use only with adequate ventilation.  Wear appropriate respirator when 
ventilation is inadequate.  Do not enter storage areas and confined spaces unless 
adequately ventilated.  Keep in the original container or an approved alternative made 
from a compatible material, kept tightly closed when not in use.  Store and use away 
from heat, sparks, open flame or any other ignition source.  Use explosion-proof 
electrical (ventilating, lighting and material handling) equipment.  Use only non-sparking 
tools.  Take precautionary measures against electrostatic discharges.  Empty containers 
retain product residue and can be hazardous.  Do not reuse container.
:
Precautions for safe handling
Special precautions : Ingestion of product or cured coating may be harmful.  Vapors may accumulate in low or 
confined areas or travel a considerable distance to a source of ignition and flash back.
Vapors are heavier than air and may spread along floors.  If this material is part of a 
multiple component system, read the Safety Data Sheet(s) for the other component or 
components before blending as the resulting mixture may have the hazards of all of its 
parts.
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strontium chromate ACGIH TLV (United States, 3/2016).
  TWA: 0.0005 mg/m³, (measured as Cr) 8 
hours.
OSHA PEL Z2 (United States, 2/2013).
  CEIL: 1 mg/10m³
OSHA PEL (United States, 6/2016).
  TWA: 0.005 mg/m³, (as Cr) 8 hours.
Formaldehyde, oligomeric reaction products with 1-chloro-2,
3-epoxypropane and phenol
None.
crystalline silica, respirable powder (<10 microns) OSHA PEL Z3 (United States, 6/2016).
  TWA: 10 mg/m³ / (%SiO2+2) 8 hours. Form:
Respirable
  TWA: 250 mppcf / (%SiO2+5) 8 hours. Form:
Respirable
OSHA PEL (United States, 6/2016).
  TWA: 50 µg/m³ 8 hours. Form: Respirable 
dust
ACGIH TLV (United States, 3/2016).
  TWA: 0.025 mg/m³ 8 hours. Form:
Respirable fraction
heptan-2-one ACGIH TLV (United States, 3/2016).
  TWA: 233 mg/m³ 8 hours.
  TWA: 50 ppm 8 hours.
OSHA PEL (United States, 6/2016).
  TWA: 465 mg/m³ 8 hours.
  TWA: 100 ppm 8 hours.
4-methylpentan-2-one ACGIH TLV (United States, 3/2016).
  STEL: 75 ppm 15 minutes.
  TWA: 20 ppm 8 hours.
OSHA PEL (United States, 6/2016).
  TWA: 410 mg/m³ 8 hours.
  TWA: 100 ppm 8 hours.
cristobalite (<10 microns) OSHA PEL Z3 (United States, 6/2016).
  TWA: 250 mppcf / 2 x (%SiO2+5) 8 hours.
Form: Respirable
  TWA: 10 mg/m³ / 2 x (%SiO2+2) 8 hours.
Form: Respirable
  TWA: 30 mg/m³ / 2 x (%SiO2+2) 8 hours.
Form: Total dust
OSHA PEL (United States, 6/2016).
  TWA: 50 µg/m³ 8 hours. Form: Respirable 
dust
ACGIH TLV (United States, 3/2016).
  TWA: 0.025 mg/m³ 8 hours. Form:
Respirable fraction
titanium dioxide OSHA PEL (United States, 6/2016).
  TWA: 15 mg/m³ 8 hours. Form: Total dust
ACGIH TLV (United States, 3/2016).
Section 8. Exposure controls/personal protection
Ingredient name Exposure limits
Control parameters
Occupational exposure limits
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Section 8. Exposure controls/personal protection
  TWA: 10 mg/m³ 8 hours.
cyclohexanone ACGIH TLV (United States, 3/2016).
Absorbed through skin. 
  STEL: 50 ppm 15 minutes.
  TWA: 20 ppm 8 hours.
OSHA PEL (United States, 6/2016).
  TWA: 200 mg/m³ 8 hours.
  TWA: 50 ppm 8 hours.
toluene OSHA PEL Z2 (United States, 2/2013).
  AMP: 500 ppm 10 minutes.
  CEIL: 300 ppm
  TWA: 200 ppm 8 hours.
ACGIH TLV (United States, 3/2016).
  TWA: 20 ppm 8 hours.
butanone ACGIH TLV (United States, 3/2016).
  STEL: 885 mg/m³ 15 minutes.
  STEL: 300 ppm 15 minutes.
  TWA: 590 mg/m³ 8 hours.
  TWA: 200 ppm 8 hours.
OSHA PEL (United States, 6/2016).
  TWA: 590 mg/m³ 8 hours.
  TWA: 200 ppm 8 hours.
[3-(2,3-epoxypropoxy)propyl]trimethoxysilane None.
ethylbenzene ACGIH TLV (United States, 3/2016).
  TWA: 20 ppm 8 hours.
OSHA PEL (United States, 6/2016).
  TWA: 435 mg/m³ 8 hours.
  TWA: 100 ppm 8 hours.
Appropriate engineering 
controls
: Use only with adequate ventilation.  Use process enclosures, local exhaust ventilation or 
other engineering controls to keep worker exposure to airborne contaminants below any 
recommended or statutory limits.  The engineering controls also need to keep gas,
vapor or dust concentrations below any lower explosive limits.  Use explosion-proof 
ventilation equipment.
Recommended monitoring 
procedures
: If this product contains ingredients with exposure limits, personal, workplace 
atmosphere or biological monitoring may be required to determine the effectiveness of 
the ventilation or other control measures and/or the necessity to use respiratory 
protective equipment.  Reference should be made to appropriate monitoring standards.
Reference to national guidance documents for methods for the determination of 
hazardous substances will also be required.
Key to abbreviations
A Acceptable Maximum Peak=
ACGIH = American Conference of Governmental Industrial Hygienists.
C = Ceiling Limit
Potential skin absorptionS
SR = Respiratory sensitization
= Skin sensitizationSS
TD = Total dust
Consult local authorities for acceptable exposure limits.
= Threshold Limit ValueTLV
TWA = Time Weighted Average
Fume=F
IPEL = Internal Permissible Exposure Limit
= Occupational Safety and Health Administration.OSHA
R = Respirable
OSHA 29 CFR 1910.1200 Subpart Z - Toxic and Hazardous Substances=Z
STEL =
=
Short term Exposure limit values
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Section 8. Exposure controls/personal protection
Hand protection Chemical-resistant, impervious gloves complying with an approved standard should be 
worn at all times when handling chemical products if a risk assessment indicates this is 
necessary.  Considering the parameters specified by the glove manufacturer, check 
during use that the gloves are still retaining their protective properties.  It should be 
noted that the time to breakthrough for any glove material may be different for different 
glove manufacturers.  In the case of mixtures, consisting of several substances, the 
protection time of the gloves cannot be accurately estimated.
Eye/face protection
Respiratory protection :
:
:
Body protection Personal protective equipment for the body should be selected based on the task being 
performed and the risks involved and should be approved by a specialist before 
handling this product.  When there is a risk of ignition from static electricity, wear anti-
static protective clothing.  For the greatest protection from static discharges, clothing 
should include anti-static overalls, boots and gloves.
:
Environmental exposure 
controls
: Emissions from ventilation or work process equipment should be checked to ensure 
they comply with the requirements of environmental protection legislation.  In some 
cases, fume scrubbers, filters or engineering modifications to the process equipment 
will be necessary to reduce emissions to acceptable levels.
Wash hands, forearms and face thoroughly after handling chemical products, before 
eating, smoking and using the lavatory and at the end of the working period.
Appropriate techniques should be used to remove potentially contaminated clothing.
Contaminated work clothing should not be allowed out of the workplace.  Wash 
contaminated clothing before reusing.  Ensure that eyewash stations and safety 
showers are close to the workstation location.
Hygiene measures :
Individual protection measures
Skin protection
Other skin protection :
Chemical splash goggles and face shield.
Gloves butyl rubber:
Appropriate footwear and any additional skin protection measures should be selected 
based on the task being performed and the risks involved and should be approved by a 
specialist before handling this product.
Respirator selection must be based on known or anticipated exposure levels, the 
hazards of the product and the safe working limits of the selected respirator.  If workers 
are exposed to concentrations above the exposure limit, they must use appropriate,
certified respirators.  Use a properly fitted, air-purifying or air-fed respirator complying 
with an approved standard if a risk assessment indicates this is necessary.
Section 9. Physical and chemical properties
Physical state
Melting point
Liquid.
Not available.
Not available.Odor
pH
Yellow.Color
Flash point Closed cup: 16.11°C (61°F)
Not available.
Not available.Odor threshold
:
:
:
:
:
:
:
Appearance
Boiling point : >37.78°C (>100°F)
Yes.:Material supports 
combustion.
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Section 9. Physical and chemical properties
Vapor pressure
Relative density
Vapor density
Solubility
1.51
Not available.
Not available.
Insoluble in the following materials: cold water.
Evaporation rate Not available.
Auto-ignition temperature Not available.
Not available.
Viscosity Kinematic (40°C (104°F)): >0.21 cm2/s (>21 cSt)
Partition coefficient: n-
octanol/water
:
:
:
:
:
:
:
:
Flammability (solid, gas) : Not available.
Lower and upper explosive 
(flammable) limits
: Not available.
Decomposition temperature : Not available.
VOC : 353 g/l
Density ( lbs / gal ) : 12.6
Section 10. Stability and reactivity
Hazardous decomposition 
products
Conditions to avoid
The product is stable.Chemical stability :
:
:
Incompatible materials :
Possibility of hazardous 
reactions
: Under normal conditions of storage and use, hazardous reactions will not occur.
Reactivity : No specific test data related to reactivity available for this product or its ingredients.
When exposed to high temperatures may produce hazardous decomposition products.
Keep away from the following materials to prevent strong exothermic reactions:
oxidizing agents, strong alkalis, strong acids.
Decomposition products may include the following materials: carbon monoxide, carbon 
dioxide, smoke, oxides of nitrogen.
Refer to protective measures listed in sections 7 and 8.
Section 11. Toxicological information
Acute toxicity
Information on toxicological effects
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Section 11. Toxicological information
strontium chromate LD50 Oral Rat 3118 mg/kg -
heptan-2-one LC50 Inhalation Vapor Rat >16.7 mg/l 4 hours
LD50 Dermal Rabbit 10.206 g/kg -
LD50 Oral Rat 1.6 g/kg -
4-methylpentan-2-one LC50 Inhalation Vapor Rat 12.3 mg/l 4 hours
LD50 Oral Rat 2.08 g/kg -
titanium dioxide LD50 Oral Rat >11 g/kg -
cyclohexanone LC50 Inhalation Gas. Rat 8000 ppm 4 hours
LC50 Inhalation Vapor Rat 11 mg/l 4 hours
LD50 Dermal Rabbit 1100 mg/kg -
LD50 Oral Rat 1.54 g/kg -
toluene LC50 Inhalation Vapor Rat 49 g/m³ 4 hours
LC50 Inhalation Vapor Rat 8000 ppm 4 hours
LD50 Dermal Rabbit 8.39 g/kg -
LD50 Oral Rat 636 mg/kg -
butanone LC50 Inhalation Vapor Rat 11243 ppm 4 hours
LD50 Dermal Rabbit 6480 mg/kg -
LD50 Oral Rat 2737 mg/kg -
[3-(2,3-epoxypropoxy)propyl]
trimethoxysilane
LC50 Inhalation Dusts and mists Rat >5300 mg/m³ 4 hours
LD50 Dermal Rabbit 4.3 g/kg -
LD50 Oral Rat 7.01 g/kg -
ethylbenzene LC50 Inhalation Vapor Rat 4000 ppm 4 hours
LD50 Dermal Rabbit 17.8 g/kg -
LD50 Oral Rat 3.5 g/kg -
Product/ingredient name Result Species Dose Exposure
Conclusion/Summary :
Carcinogenicity
Conclusion/Summary :
Mutagenicity
Conclusion/Summary :
Irritation/Corrosion
Conclusion/Summary
Skin :
Eyes :
Respiratory :
Sensitization
Conclusion/Summary
Skin :
Respiratory :
Classification
There are no data available on the mixture itself.
There are no data available on the mixture itself.
There are no data available on the mixture itself.
There are no data available on the mixture itself.
There are no data available on the mixture itself.
There are no data available on the mixture itself.
There are no data available on the mixture itself.
There are no data available on the mixture itself.
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Section 11. Toxicological information
Teratogenicity
Conclusion/Summary :
Reproductive toxicity
Conclusion/Summary :
Specific target organ toxicity (single exposure)
strontium chromate + 1 Known to be a human carcinogen.
crystalline silica, respirable 
powder (<10 microns)
- 1 Known to be a human carcinogen.
4-methylpentan-2-one - 2B -
cristobalite (<10 microns) - 1 Known to be a human carcinogen.
titanium dioxide - 2B -
cyclohexanone - 3 -
toluene - 3 -
ethylbenzene - 2B -
Product/ingredient name NTPIARCOSHA
Carcinogen Classification code:
IARC: 1, 2A, 2B, 3, 4
NTP:  Known to be a human carcinogen; Reasonably anticipated to be a human carcinogen
OSHA:  +
Not listed/not regulated:  -
There are no data available on the mixture itself.
There are no data available on the mixture itself.
Name
Information on the likely routes of exposure
Specific target organ toxicity (repeated exposure)
4-methylpentan-2-one Category 3
toluene Category 3
butanone Category 3
Category
Name Category
strontium chromate Category 2
crystalline silica, respirable powder (<10 microns) Category 1
cristobalite (<10 microns) Category 1
toluene Category 2
ethylbenzene Category 2
Aspiration hazard
Name Result
toluene ASPIRATION HAZARD - Category 1
ethylbenzene ASPIRATION HAZARD - Category 1
Potential acute health effects
Target organs : Contains material which causes damage to the following organs: blood, liver, spleen,
brain, skin, bone marrow.
Contains material which may cause damage to the following organs: kidneys, lungs, the 
nervous system, the reproductive system, heart, peripheral nervous system,
cardiovascular system, upper respiratory tract, immune system, bones, central nervous 
system (CNS), eye, lens or cornea.
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Section 11. Toxicological information
Conclusion/Summary :
Delayed and immediate effects and also chronic effects from short and long term exposure
Short term exposure
Inhalation : Harmful if inhaled.
Harmful if swallowed.:Ingestion
Skin contact : Causes skin irritation.  Defatting to the skin.  May cause an allergic skin reaction.
Causes serious eye damage.:Eye contact
Over-exposure signs/symptoms
Skin contact
Ingestion
Inhalation Adverse symptoms may include the following:
reduced fetal weight
increase in fetal deaths
skeletal malformations
Adverse symptoms may include the following:
stomach pains
reduced fetal weight
increase in fetal deaths
skeletal malformations
Adverse symptoms may include the following:
pain or irritation
redness
dryness
cracking
blistering may occur
reduced fetal weight
increase in fetal deaths
skeletal malformations
:
:
:
Eye contact : Adverse symptoms may include the following:
pain
watering
redness
There are no data available on the mixture itself.  Trimethoxysilanes are capable of 
forming methanol if hydrolyzed or ingested. If swallowed, methanol may be harmful or 
fatal or cause blindness.  This product either contains formaldehyde or is capable of 
releasing formaldehyde above 0.5 ppm under certain conditions. Formaldehyde is a 
known cancer hazard, a skin sensitizer and a respiratory sensitizer.  This product 
contains crystalline silica which can cause lung cancer or silicosis.  The risk of cancer 
depends on the duration and level of exposure to dust from sanding surfaces or mist 
from spray applications.  Exposure to component solvent vapor concentrations in 
excess of the stated occupational exposure limit may result in adverse health effects 
such as mucous membrane and respiratory system irritation and adverse effects on the 
kidneys, liver and central nervous system.  Symptoms and signs include headache,
dizziness, fatigue, muscular weakness, drowsiness and, in extreme cases, loss of 
consciousness.  Solvents may cause some of the above effects by absorption through 
the skin.  There is some evidence that repeated exposure to organic solvent vapors in 
combination with constant loud noise can cause greater hearing loss than expected 
from exposure to noise alone.  If splashed in the eyes, the liquid may cause irritation 
and reversible damage.  Ingestion may cause nausea, diarrhea and vomiting.  This 
takes into account, where known, delayed and immediate effects and also chronic 
effects of components from short-term and long-term exposure by oral, inhalation and 
dermal routes of exposure and eye contact.
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Section 11. Toxicological information
General :
Carcinogenicity :
Mutagenicity :
Teratogenicity :
Developmental effects :
Fertility effects :
Potential chronic health effects
Numerical measures of toxicity
Oral 869.3 mg/kg
Dermal 16259.4 mg/kg
Inhalation (gases) 15586.5 ppm
Inhalation (vapors) 36.18 mg/l
Inhalation (dusts and mists) 5.896 mg/l
Route ATE value
Acute toxicity estimates
Potential immediate 
effects
:
Potential delayed effects :
Potential immediate 
effects
:
Long term exposure
Potential delayed effects :
May cause cancer.  Risk of cancer depends on duration and level of exposure.
Causes damage to organs through prolonged or repeated exposure.  Prolonged or 
repeated contact can defat the skin and lead to irritation, cracking and/or dermatitis.
Once sensitized, a severe allergic reaction may occur when subsequently exposed to 
very low levels.
Suspected of damaging the unborn child.
No known significant effects or critical hazards.
No known significant effects or critical hazards.
No known significant effects or critical hazards.
There are no data available on the mixture itself.
There are no data available on the mixture itself.
There are no data available on the mixture itself.
There are no data available on the mixture itself.
Section 12. Ecological information
Bioaccumulative potential
Product/ingredient name Aquatic half-life Photolysis Biodegradability
toluene - - Readily
ethylbenzene - - Readily
Toxicity
titanium dioxide Acute LC50 >100 mg/l Fresh water Daphnia - Daphnia magna 48 hours
ethylbenzene Acute LC50 150 to 200 mg/l Fresh water Fish - Lepomis macrochirus -
Young of the year
96 hours
Product/ingredient name SpeciesResult Exposure
Persistence and degradability
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Section 12. Ecological information
LogPow BCF PotentialProduct/ingredient name
heptan-2-one 1.98 - low
4-methylpentan-2-one 1.31 - low
cyclohexanone 0.81 - low
toluene 2.73 8.32 low
butanone 0.29 - low
ethylbenzene 3.15 79.43 low
Soil/water partition 
coefficient (KOC)
: Not available.
Mobility in soil
Section 13. Disposal considerations
The generation of waste should be avoided or minimized wherever possible.  Disposal 
of this product, solutions and any by-products should at all times comply with the 
requirements of environmental protection and waste disposal legislation and any 
regional local authority requirements.  Dispose of surplus and non-recyclable products 
via a licensed waste disposal contractor.  Waste should not be disposed of untreated to 
the sewer unless fully compliant with the requirements of all authorities with jurisdiction.
Waste packaging should be recycled.  Incineration or landfill should only be considered 
when recycling is not feasible.  This material and its container must be disposed of in a 
safe way.  Care should be taken when handling emptied containers that have not been 
cleaned or rinsed out.  Empty containers or liners may retain some product residues.
Vapor from product residues may create a highly flammable or explosive atmosphere 
inside the container.  Do not cut, weld or grind used containers unless they have been 
cleaned thoroughly internally.  Avoid dispersal of spilled material and runoff and contact 
with soil, waterways, drains and sewers.
:Disposal methods
Disposal should be in accordance with applicable regional, national and local laws and regulations.
Refer to Section 7: HANDLING AND STORAGE and Section 8: EXPOSURE CONTROLS/PERSONAL PROTECTION 
for additional handling information and protection of employees. Section 6. Accidental release measures
14. Transport information
PAINT
3
II
PAINT
3
II
PAINT
UN1263
3
II
UN1263 UN1263
DOT IMDG IATA
UN number
UN proper shipping 
name
Transport hazard class
(es)
Packing group
Environmental hazards No. Yes. Yes. The environmentally 
hazardous substance mark is 
not required.
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14. Transport information
Marine pollutant 
substances
Not applicable.(strontium chromate,
Formaldehyde, oligomeric 
reaction products with 1-chloro-
2,3-epoxypropane and phenol)
RQ substances
37.829
(strontium chromate, xylene)
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Special precautions for user Transport within user’s premises: always transport in closed containers that are 
upright and secure. Ensure that persons transporting the product know what to do in 
the event of an accident or spilage.
:
Additional information
Package sizes shipped in quantities less than the product reportable quantity are not subject to the 
RQ (reportable quantity) transportation requirements.
The marine polutant mark is not required when transported in sizes of ≥5 L or ≥5 kg.
DOT
IMDG
:
:
IATA : The environmentaly hazardous substance mark may appear if required by other transportation 
regulations.
Product RQ (lbs)
Section 15. Regulatory information
SARA 302/304
SARA 304 RQ : Not applicable.
Composition/information on ingredients
SARA 311/312
Classification : Fire hazard
Immediate (acute) health hazard
Delayed (chronic) health hazard
strontium chromate No. No. No. Yes. Yes. -
Formaldehyde, oligomeric reaction 
products with 1-chloro-2,
3-epoxypropane and phenol
No. No. No. Yes. No. -
crystaline silica, respirable powder 
(<10 microns)
No. No. No. No. Yes. -
heptan-2-one Yes. No. No. Yes. No. -
4-methylpentan-2-one Yes. No. No. Yes. Yes. -
Name Fire 
hazard
Sudden 
release of 
pressure
Reactive Immediate 
(acute)
health 
hazard
Delayed 
(chronic)
health 
hazard
Composition/information on ingredients
Al components are listed or exempted.United States inventory (TSCA 8b) :
United States
United States - TSCA 12(b) - Chemical export notification:
strontium chromate Annual notification
No products were found.
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Section 15. Regulatory information
SARA 313
SARA 313 notifications must not be detached from the SDS and any copying and redistribution of the SDS shall include 
copying and redistribution of the notice attached to copies of the SDS subsequently redistributed.
cristobalite (<10 microns) No. No. No. No. Yes. -
titanium dioxide No. No. No. No. Yes. -
cyclohexanone Yes. No. No. Yes. No. -
toluene Yes. No. No. Yes. Yes. -
butanone Yes. No. No. Yes. No. -
[3-(2,3-epoxypropoxy)propyl]
trimethoxysilane
No. No. No. Yes. No. -
ethylbenzene Yes. No. No. Yes. Yes. -
California Prop. 65
WARNING: This product contains a chemical known to the State of California to cause cancer and birth defects or other 
reproductive harm.
Supplier notification
Chemical name
: strontium chromate 7789-06-2 10 -  30
4-methylpentan-2-one 108-10-1 3 - 7
toluene 108-88-3 1 - 5
ethylbenzene 100-41-4 0.1 - 1
CAS number Concentration
Section 16. Other information
Key to abbreviations : ATE = Acute Toxicity Estimate
BCF = Bioconcentration Factor
GHS = Globally Harmonized System of Classification and Labelling of Chemicals
IATA = International Air Transport Association
IBC = Intermediate Bulk Container
IMDG = International Maritime Dangerous Goods
LogPow = logarithm of the octanol/water partition coefficient
MARPOL = International Convention for the Prevention of Pollution From Ships, 1973 
as modified by the Protocol of 1978. ("Marpol" = marine pollution)
UN = United Nations
Hazardous Material Information System (U.S.A.)
3
03
National Fire Protection Association (U.S.A.)
Health InstabilityFlammability
Health Flammability Physical hazards
Disclaimer
Date of previous issue 12/19/2016:
Caution: HMIS® ratings are based on a 0-4 rating scale, with 0 representing minimal hazards or risks, and 4 representing significant hazards or 
risks Although HMIS® ratings are not required on MSDSs under 29 CFR 1910.1200, the preparer may choose to provide them. HMIS® ratings are 
to be used with a fully implemented HMIS® program. HMIS® is a registered mark of the National Paint & Coatings Association (NPCA). HMIS® 
materials may be purchased exclusively from J. J. Keller (800) 327-6868.
The customer is responsible for determining the PPE code for this material.
Indicates information that has changed from previously issued version.
Organization that prepared 
the MSDS
: EHS
:: :
: : :3 *
3
0
( * ) - Chronic effects
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Section 16. Other information
The information contained in this data sheet is based on present scientific and technical knowledge.  The purpose of this 
information is to draw attention to the health and safety aspects concerning the products supplied by PPG, and to 
recommend precautionary measures for the storage and handling of the products. No warranty or guarantee is given in 
respect of the properties of the products. No liability can be accepted for any failure to observe the precautionary measures 
described in this data sheet or for any misuse of the products.
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